Status:
UNKNOWN
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
Lead Sponsor:
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Conditions:
Anemia
Iron-deficiency
Eligibility:
All Genders
3-3 years
Phase:
PHASE4
Brief Summary
This study compares weekly versus daily administration of iron for prevention of anemia in 6 months old infants. One third of the infants that are exclusively breast fed will not receive iron, the sec...
Detailed Description
Iron deficiency is the most prevalent nutritional deficiency and the main cause of anemia. It's estimated that 43% of pre-school children worldwide are anemic, in Argentina a national survey carried o...
Eligibility Criteria
Inclusion
- 3 months old infants, clinically healthy, born to term (\>37 weeks), that weighted at birth between 2500 and 4000 g, that have normal prenatal records.
Exclusion
- anemic or iron deficient infants, or that have a chronic pathology, or that have undergone an acute pathology in the previous 15 days. Children that are receiving antibiotics or vitamin supplements.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT03359447
Start Date
August 1 2017
End Date
August 1 2019
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
La Plata, Buenos Aires, Argentina, 1900